CUAMC
TSHA icon

China Universal Asset Management Company’s Taysha Gene Therapies TSHA Stock Holding History

China Universal Asset Management Company’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$448K Buy
65,734
+17,125
+35% +$101K 0.03% 274
2026
Q1 		$217K Buy
48,609
+3,974
+9% +$18.5K 0.02% 346
2025
Q4 		$245K Sell
44,635
-3,182
-7% -$15.5K 0.02% 324
2025
Q3 		$156K Sell
47,817
-4,710
-9% -$13.3K 0.01% 350
2025
Q2 		$121K Buy
52,527
+11,407
+28% +$24.8K 0.01% 347
2025
Q1 		$57.2K Sell
41,120
-2,336
-5% -$3.91K 0.01% 410
2024
Q4 		$75.2K Buy
43,456
+4,039
+10% +$8.38K 0.01% 419
2024
Q3 		$79.2K Buy
39,417
+17,446
+79% +$38.3K 0.01% 370
2024
Q2 		$49.2K Sell
21,971
-13,937
-39% -$40.6K 0.01% 357
2024
Q1 		$103K Buy
35,908
+14,286
+66% +$29.8K 0.01% 369
2023
Q4 		$38.3K Buy
+21,622
New +$43.1K 0.01% 392
2022
Q4 		– Sell
-385
Closed -$1K – 468
2022
Q3 		$1K Buy
+385
New +$1.4K ﹤0.01% 418

Other funds holding TSHA

AWM
Affinity Wealth Management Wilmington, Delaware $776M AUM 43.59% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
RRA
Red Reef Advisors Boca Raton, Florida $108M AUM
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
WN
Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return
LF
Lee Financial Dallas, Texas $783M AUM 23.98% 1-Year Est. Return
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

China Universal Asset Management Company's TSHA Position: Q2 2026 in Review

China Universal Asset Management Company increased its Taysha Gene Therapies (TSHA) stake by 35% in Q2 2026, buying an estimated $101K and bringing the position to 65,734 shares worth $448K. The position accounts for 0.03% of the portfolio, ranked #274.

China Universal Asset Management Company first reported a position in TSHA in Q3 2022 and has held it in 12 quarters since. 20 funds tracked by Wall St. Rank hold TSHA as of Q2 2026.

  • China Universal Asset Management Company held 65,734 shares of Taysha Gene Therapies worth $448K as of Q2 2026.
  • China Universal Asset Management Company bought 17,125 Taysha Gene Therapies shares in Q2 2026, an estimated $101K.
  • Taysha Gene Therapies made up 0.03% of China Universal Asset Management Company's portfolio in Q2 2026, its #274 holding.
  • China Universal Asset Management Company first reported a position in Taysha Gene Therapies in Q3 2022 and has held it in 12 quarters since.
  • 20 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.